TAK

Takeda Pharmaceutical Company Limited $18.26 1M +4.9% 3M +15.1% YTD +16.9% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
+0.2%
Next 1 month
-1.5%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -4.3% median, 20% of the last 15 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 60
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.06%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.19 -0.0% · Seasonal tilt -1.5%
$57.6B market cap (#299 US) $40M/day volume 21% volatility +19% 1-year -42% from ATH
52-week range · 89% of the way up · -3% from the high
$12.99$18.90

Congressional trades in TAK Full tracker →

4 members · 3 buys / 4 sells · $63K–$245K disclosed · latest filing Sep 5, 2023.

SELL VF Virginia Foxx · traded Aug 29, 2023 $15K–$50K
SELL DG Daniel Goldman · traded Jul 10, 2023 $15K–$50K
BUY VF Virginia Foxx · traded Feb 16, 2023 $1K–$15K
BUY VF Virginia Foxx · traded Nov 1, 2022 $1K–$15K
SELL GG Greg Gianforte · traded Sep 11, 2019 $1K–$15K
SELL NT Nicholas Van Taylor · traded Mar 25, 2019 $15K–$50K
BUY GG Greg Gianforte · traded Dec 21, 2018 $15K–$50K

Earnings Full history →

Next report 2026-10-29 (Thursday, before open, in 45 days).

1-day std dev
1.5%
Finished up
56%
Biggest pop
+2.1%
Biggest drop
-2.5%

Standard deviation of the close-to-close move over the last 9 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.